Clough Capital Partners L P Ardelyx, Inc. Transaction History

Clough Capital Partners L P

  • $924 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$3.29 - $6.64 $39,078 - $78,869
-11,878 Reduced 14.79%
68,422 $424,000
Q3 2023

Nov 14, 2023
SELL
$3.3 - $4.83 $3.27 Million - $4.78 Million
-990,600 Reduced 92.5%
80,300 $327,000
Q2 2023

Aug 14, 2023
BUY
$3.23 - $4.95 $3.46 Million - $5.3 Million
1,070,900 New
1,070,900 $3.63 Million

Others Institutions Holding ARDX

# of Institutions
219
Shares Held
141M
Call Options Held
1.08M
Put Options Held
2M
View Full List

About ARDELYX, INC.

ARDX Quotes by TradingView
  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $815M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Clough Capital Partners L P Portfolio

Follow Clough Capital Partners L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clough Capital Partners L P, based on Form 13F filings with the SEC.

News

Stay updated on Clough Capital Partners L P with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email